| __timestamp | Ligand Pharmaceuticals Incorporated | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22570000 | 2917513 |
| Thursday, January 1, 2015 | 24378000 | 7878291 |
| Friday, January 1, 2016 | 26621000 | 8366794 |
| Sunday, January 1, 2017 | 28653000 | 6610381 |
| Monday, January 1, 2018 | 37734000 | 6556000 |
| Tuesday, January 1, 2019 | 41884000 | 6930000 |
| Wednesday, January 1, 2020 | 64435000 | 8758000 |
| Friday, January 1, 2021 | 57483000 | 10806000 |
| Saturday, January 1, 2022 | 70062000 | 9844000 |
| Sunday, January 1, 2023 | 52790000 | 13481000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. Over the past decade, Ligand Pharmaceuticals Incorporated and Soleno Therapeutics, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. Ligand Pharmaceuticals has seen a significant increase, with expenses peaking in 2022, marking a 210% rise from 2014. This growth reflects their aggressive expansion and investment in operational capabilities. In contrast, Soleno Therapeutics has maintained a more conservative approach, with a steady increase of approximately 360% over the same period, indicating a focus on sustainable growth.
These trends highlight the strategic priorities of each company. Ligand's higher SG&A expenses suggest a focus on scaling operations, while Soleno's steady increase points to a balanced approach, ensuring financial stability while pursuing growth opportunities.
Regeneron Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Insmed Incorporated and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Soleno Therapeutics, Inc. Trends and Insights
Pharming Group N.V. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Perrigo Company plc and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of ImmunityBio, Inc. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Celldex Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Soleno Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Soleno Therapeutics, Inc. or Viridian Therapeutics, Inc.